Tirzepatide is primarily used in the treatment of type 2 diabetes. It works by improving blood sugar control through a dual action on both GLP-1 and GIP receptors, which helps to increase insulin secretion and reduce glucagon levels. This leads to better management of blood glucose levels throughout the day. Additionally, it has been shown to promote weight loss, making it beneficial for patients who are overweight or obese. The medication is administered via subcutaneous injection, typically once a week, offering convenience for long-term management. Beyond diabetes, tirzepatide is being explored for its potential in treating obesity and related metabolic disorders, providing a promising option for comprehensive metabolic health improvement.